Israel Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
1. Israel Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 89
Price: Single User License – US$2500
Israel Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “Israel Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery” provides key market data on the Israel Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Israel Diabetes Care
Devicesmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Sanofi,
Medtronic, Inc., Novo Nordisk A/S, Bayer HealthCare AG and others.
2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Israel Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197500-israel-diabetes-care-devices-market-outlook-to-2018-glucose-
monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What is This Report About? 8
3 Diabetes Care Devices In Israel 9
3.1 Diabetes Care Devices, Market Segmentation 9
3.2 Diabetes Care Devices, Israel, Overall Revenue ($m), USD Constant, 2004-2018 10
3.3 Diabetes Care Devices Market, Israel, Revenue Mix ($m), 2011 11
3.4 Diabetes Care Devices Market, Israel, Category Contribution (%), 2011 12
3.5 Diabetes Care Devices, Israel, Company Share (2010-2011) 19
4 Glucose Monitoring In Israel 21
4.1 Glucose Monitoring, Market Segmentation 21
4.2 Glucose Monitoring Market, Israel, Revenue Mix ($m), 2011 22
4.3 Glucose Monitoring Market, Israel, Segment Contribution (%), 2011 23
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 24
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 28
4.5 Glucose Monitoring Overall Volume (2004-2018) 32
4.5.1 Blood Glucose Meters, Volume (2004-2018) 36
4.6 Glucose Monitoring Average Price (2004-2018) 38
4.7 Glucose Monitoring Distribution Share (2010-2011) 39
4.8 Glucose Monitoring, Israel, Company Share (2010-2011) 40
5 Insulin Delivery In Israel 42
5.1 Insulin Delivery, Market Segmentation 42
5.2 Insulin Delivery Market, Israel, Revenue Mix ($m), 2011 43
3. 5.3 Insulin Delivery Market, Israel, Segment Contribution (%), 2011 44
5.4 Insulin Delivery Overall Revenue, (2004-2018) 45
5.4.1 Insulin Pens, Revenue (2004-2018) 49
5.4.2 Insulin Pumps, Revenue (2004-2018) 53
5.5 Insulin Delivery Overall Volume (2004-2018) 57
5.5.1 Insulin Pens, Volume (2004-2018) 61
5.5.2 Insulin Pumps, Volume (2004-2018) 65
5.6 Insulin Delivery Average Price (2004-2018) 67
5.7 Insulin Delivery Distribution Share (2010-2011) 68
5.8 Insulin Delivery, Israel, Company Share (2010-2011) 69
6 Overview of Key Companies in Israel Diabetes Care Devices Market 71
6.1 F. Hoffmann-La Roche Ltd. 71
6.1.1 Company Overview 71
6.1.2 Share in the Israel Diabetes Care Devices Market 71
6.2 Eli Lilly and Company 72
6.2.1 Company Overview 72
6.2.2 Share in the Israel Diabetes Care Devices Market 72
6.3 Sanofi 73
6.3.1 Company Overview 73
6.3.2 Share in the Israel Diabetes Care Devices Market 73
6.4 Medtronic, Inc. 74
6.4.1 Company Overview 74
6.4.2 Share in the Israel Diabetes Care Devices Market 74
6.5 Novo Nordisk A/S 75
6.5.1 Company Overview 75
6.5.2 Share in the Israel Diabetes Care Devices Market 75
6.6 Bayer HealthCare AG 76
6.6.1 Company Overview 76
6.6.2 Share in the Israel Diabetes Care Devices Market 76
6.7 Animas Corporation 77
6.7.1 Company Overview 77
6.8 Abbott Laboratories 77
6.8.1 Company Overview 77
6.9 Becton, Dickinson and Company 77
6.9.1 Company Overview 77
6.10 Insulet Corporation 78
6.10.1 Company Overview 78
6.11 BIONIME Corporation 78
6.11.1 Company Overview 78
6.12 Terumo Corporation 79
6.12.1 Company Overview 79
6.13 Nipro Corporation 79
4. 6.13.1 Company Overview 79
7 Diabetes Care Devices Market Pipeline Products 80
8 Appendix 83
8.1 Definitions of Markets Covered in the Report 84
8.1.1 Diabetes Care Devices 84
8.2 Research Methodology 86
8.3 Secondary Research 86
8.4 Primary Research 87
8.5 Models 87
8.6 Forecasts 88
8.7 Expert Panels 88
8.8 GlobalData Consulting 88
8.9 Currency Conversion 88
8.10 Contact Us 88
8.11 Disclaimer 89
1.1 List of Tables
Table 1: Diabetes Care Devices, Israel, Overall Revenue ($m), USD Constant, 2004-2018 10
Table 2: Diabetes Care Devices Market, Israel, Category Contribution (%), 2011 12
Table 3: Diabetes Care Devices, Israel, Cross-Segment Analysis, 2004-2018 14
Table 4: Diabetes Care Devices, Israel, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 16
Table 5: Diabetes Care Devices, Israel, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 18
Table 6: Diabetes Care Devices, Israel, Company Share by Revenue ($m), USD Constant, 2010-
2011 20
Table 7: Glucose Monitoring Market, Israel, Segment Contribution (%), 2011 23
Table 8: Glucose Monitoring, Israel, Revenue ($m) USD Constant, by Segment , Historic, 2004-
2011 25
Table 9: Glucose Monitoring, Israel, Revenue ($m) USD Constant, by Segment , Forecast, 2011-
2018 27
Table 10: Blood Glucose Meters, Israel, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 29
Table 11: Blood Glucose Meters, Israel, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 31
Table 12: Glucose Monitoring, Israel, Volume (Units) by Segment, Historic, 2004-2011 33
Table 13: Glucose Monitoring, Israel, Volume (Units) by Segment, Forecast, 2011-2018 35
Table 14: Blood Glucose Meters, Israel, Volume (Units) by Sub-Segment, Historic, 2004-2011 36
Table 15: Blood Glucose Meters, Israel, Volume (Units) by Sub-Segment, Forecast, 2011-2018 37
Table 16: Glucose Monitoring, Israel, Average Price ($), Historic, 2004-2011 38
Table 17: Glucose Monitoring, Israel, Average Price ($), Forecast, 2011-2018 38
Table 18: Glucose Monitoring, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-